Sam Backenroth
2016 - Ohr Pharmaceutical
In 2016, Sam Backenroth earned a total compensation of $911.7K as Chief Financial Officer at Ohr Pharmaceutical, a 37% increase compared to previous year.
Compensation breakdown
| Bonus | $107,500 |
|---|---|
| Salary | $200,000 |
| Stock Awards | $587,600 |
| Other | $16,620 |
| Total | $911,720 |
Backenroth received $587.6K in stock awards, accounting for 64% of the total pay in 2016.
Backenroth also received $107.5K in bonus, $200K in salary and $16.6K in other compensation.
Rankings
In 2016, Sam Backenroth's compensation ranked 8,675th out of 14,075 executives tracked by ExecPay. In other words, Backenroth earned more than 38.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,675 out of 14,075 | 38th |
Division Manufacturing | 3,349 out of 5,489 | 39th |
Major group Chemicals And Allied Products | 1,138 out of 1,895 | 40th |
Industry group Drugs | 894 out of 1,538 | 42nd |
Industry Pharmaceutical Preparations | 711 out of 1,176 | 40th |
Source: SEC filing on September 7, 2018.
Backenroth's colleagues
We found two more compensation records of executives who worked with Sam Backenroth at Ohr Pharmaceutical in 2016.